Stempoint Capital »

Vaxcyte shares owned by Stempoint Capital

Quarter-by-quarter ownership of Vaxcyte (PCVX) shares owned by Stempoint Capital from 13F filings

Historical chart of Stempoint Capital investment in Vaxcyte

Tip: Access up to 7 years of quarterly data

All positions including Vaxcyte held by Stempoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaxcyte by Stempoint Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.4M 59k 58.11

More positions owned by Stempoint Capital

Abivax Sa Sponsored Ads (ABVX)
Abivax Sa Sponsored Ads (ABVX)
Praxis Precision Medicines I Com New (PRAX)
Praxis Precision Medicines I Com New (PRAX)
Surrozen Com New (SRZN)
Mbx Biosciences (MBX)
Mbx Biosciences (MBX)
Mineralys Therapeutics (MLYS)
Mineralys Therapeutics (MLYS)
Enliven Therapeutics (ELVN)
Enliven Therapeutics (ELVN)
Cg Oncology (CGON)
Cg Oncology (CGON)
Biohaven (BHVN)
Biohaven (BHVN)

View all positions for Stempoint Capital

Top funds holding Vaxcyte

Henderson Group
FMR
Vanguard Group
RA Capital Management
T. Rowe Price Investment Management
BlackRock
Vanguard Portfolio Management
Vanguard Capital Management
Wellington Management Company
State Street Corporation
Paradigm Biocapital Advisors
Deep Track Capital
Westfield Capital Management Company
Geode Capital Management
Kynam Capital Management

View all funds holding Vaxcyte